What is rectal cancer? Dostarlimab a new medicine for it ~ Total Health Solutions (Unit of Catch Creative Concepts)

What is rectal cancer? Dostarlimab a new medicine for it


What is rectal cancer ||
The discovery of a drug named Dostarlimab has brought great news, because the cancer is no longer incurable. This medicine was given to 18 patients of rectal cancer, for 6 months these patients took the medicine and after 6 months all the 18 patients became completely cancer free. After all, what is this rectal cancer and how is this medicine curing cancer patients, let us know.

"Dostarlimab" (A new medicine for rectal cancer)
All 18 rectal cancer patients who participated in a clinical trial in the United States were cured. This medical miracle has happened at the country's famous Memorial Sloan Kettering Cancer Center. Experts say this is perhaps the first time in the history of modern medical science that an experimental procedure has been so successful against the most dangerous disease. As indicated by media reports, 18 patients took a medication called dostarlimab for a long time. In all patients, cancerous tumors disappeared within 6 months of treatment alone. A researcher at the New York-based hospital, Dr. Louis A. Diaz J said that this is a great success in mankind's war against cancer.

What is rectal cancer?
In rectal cancer, malignant cancer cells form in the tissues of the rectum. One of the major symptoms of colon cancer is blood in the stool. Apart from this, itching in the anus area, redness etc. can also be its symptoms. The rectum is a part of the body's extensive digestive system. The rectum and anus are the last two parts of the system and serve to remove waste material from the body after digestion. According to reports, the overall five-year survival rate for rectal cancer is 63 percent. The five-year survival rate for people whose cancer has not spread through the rectum is 91 percent.

Symptoms of rectal cancer
In rectal cancer, blood in the stool, constipation, diarrhea, abnormal shape of the stool, gas, abdominal pain, bloating, change in appetite, sudden weight loss, fatigue, etc.

What is dostarlimab?
Dostarlimab is an experimental drug. It consists of molecules created by the laboratory. It acts as a substitute antibody. It is sold under the brand name Gemperly. It was approved for medical use in the United States and the European Union in 2021. Its side effects include vomiting, joint pain, itching, rash, fever, etc.

The 18 patients who participated in the study had cancer in the rectal and the cancer had not spread to other parts of the body. These patients were planning to undergo conventional cancer treatments such as chemotherapy, radiation and surgery. However, when he became a part of this experiment and when the result came, there were tears of joy in everyone's eyes. However, the effectiveness of the drug cannot be ascertained in such a small trial. A very large study involving a large number of patients would have to be done to draw a final picture as to the effectiveness of the drug.

Sources and references

Disclaimer: The related article has been prepared to increase the knowledge and awareness of the reader. THS and CCC do not claim nor take any responsibility for the information and information provided in the article. Counsel your Physician for additional insights concerning the connected illness referenced in the above article.

Garcinia Cambogia



tags #what is rectal cancer #what is rectal cancer called #what is rectal cancer surgery #what is rectal cancer survival rate #what is rectal cancer stage 4 #what is colon cancer #what is colorectal cancer #dostarlimab price #dostarlimab price in india #dostarlimab cancer #dostarlimab cost #dostarlimab side effects #dostarlimab india #dostarlimab drug #dostarlimab breast cancer,

Previous
Next Post »